| 28 Mar 2009 |
|
Globalpharma looks to expand regional footprint with strong participation at DUPHAT 2009
- Text size
Middle East's leading pharmaceutical company will present its latest products including antihypertensives and pain relievers as well as a new weight loss product that is set to hit markets this April
Dubai - UAE March 28, 2009: As part of its strategy to increase its market share in the Middle East, GlobalpharmaGlobalpharma
, a subsidiary of Dubai Investments IndustriesDubai Investments Industries (DII)(DII) and a leading player in the regional pharmaceutical industry, has announced its strong participation at the Dubai International Pharmaceuticals and Technologies Conference Exhibition (DUPHAT) 2009. unveil its latest products and present an overview of breakthrough products set for imminent launch. The company will present its new range of products including antihypertensives and pain relievers, as well as a new weight loss product that will be launched in regional markets in April 2009. This is the 3rd consecutive year that GlobalpharmaGlobalpharma is participating in DUPHAT, which takes place from March 29th to 31st at the Dubai International Convention and Exhibition Centre. GlobalpharmaGlobalpharma will be located at Stand I and II at the Sheikh Maktoum Hall of the exhibition centre.
"As the largest annual exhibition for the region's pharmaceutical industry, DUPHAT offers us unparalleled brand visibility and excellent networking possibilities," said Jamil Akhtar, General Manager of GlobalpharmaGlobalpharma. "The event attracts the biggest names from the pharma industry and brings together key regional decision-makers, giving us an opportunity to explore strategic alliances and reinforce our relationship with health ministries and regulatory authorities from the UAE and other regional countries."
"While the global financial crisis has left virtually no economic sector completely untouched, pharmaceutical remains one of the least affected industries, and this is especially true of the pharmaceutical market in the Middle East, where analysts forecast massive, sustained growth over the next few years. Liberalization of domestic economies, combined with strong governmental efforts to encourage indigenous manufacture of pharmaceutical products, have been key growth drivers for Middle East's pharma industry," Akhtar added.
GlobalpharmaGlobalpharma is Dubai's first pharmaceutical manufacturing company, manufacturing and marketing pharmaceutical products in more than 20 countries across the Middle East, Africa and Far East. Established in 1998, the company has developed into a major player in the MEA pharmaceutical market, earning a reputation for quality and reliability.
-Ends-
Media Contacts:
Mitha Furtado
Headline Public Relations
Tel: 9714 - 2289655 Ext 101
Fax: 9714 - 2282125
Email: mitha@headlinepr.com
© Press Release 2009
Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.
Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Post a Comment
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse.